Skip to main content
Clinical Trials/PACTR202309743823347
PACTR202309743823347
Not yet recruiting
未知

se of continuous glucose monitoring devices among people living with type 1 diabetes in Kenya: A three-arm pragmatic randomized study on the effectiveness, feasibility, acceptability, and cost.

Foundation for Innovative New Diagnostics0 sites246 target enrollmentJune 13, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Foundation for Innovative New Diagnostics
Enrollment
246
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 13, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Recipient of care participants are eligible to be included in the Study only if all the following inclusion criteria apply:
  • People living with T1 diabetes with HbA1c levels \=10% (with at least 1 measurement over 18 months prior to study enrolment) who are attending for diabetes care at the 3 study clinics.
  • Care givers to children/adolescents living with T1 diabetes are eligible to be included in the study only if all the following inclusion criteria apply:
  • The child/adolescent that the person is a care giver to is enrolled in the study.
  • Healthcare providers are eligible to be included in the study only if all the following inclusion criteria apply:
  • Healthcare provider at the study sties engaged in diabetes care provision related to the study.

Exclusion Criteria

  • People living with type 1 diabetes under 4 years of age.
  • People diagnosed with Type 1 diabetes within the last 2 years.
  • People who have used a CGM in the last 18 months prior to enrollment
  • People living with type 2 diabetes.
  • Known pregnancy at the time of study enrolment.

Outcomes

Primary Outcomes

Not specified

Similar Trials